[1] |
BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing.
Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724.
|
[2] |
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang.
Study of the serum concentration at two time points after taking rifampicin
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 493-497.
|
[3] |
ZHOU Yin-fa,ZHANG Shan-ying,DAI Zhi-song,CHEN Dai-quan,LI Wei-lin,ZHAO Yong,LIN Shu-fang.
Prevalence and influencing factors of rifampicin resistance among high-risk group of drug-resistant tuberculosis in Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 339-344.
|
[4] |
FAN Lin,LIU Yi-dian,XIAO He-ping.
Characteristics and points analysis of national Guidelines on chemotherapy of drug-resistant tuberculosis (2019) and associated consensus
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 91-94.
|
[5] |
Maimaitiaili ·Aihemuti, HUANG Qiao-ling, Guerseman ·Abula, Renati ·Ailaiti.
Analysis of drug-resistance to rifampin and isoniazid in 1307 patients with pulmonary tuberculosis in Kashi, Xinjiang
[J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1209-1213.
|
[6] |
ZHANG Man-e,HUANG Wen-bin,LU Zhi-hua,ZHANG Hong-bin.
Study on resistance to rifampicin and isoniazid in 411 cases of pulmonary tuberculosis in Longyan City, Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(1): 54-59.
|
[7] |
Yuan LIU,Jun ZHOU,Xiao-li CUI,Jia-yuan LEI,Li-yun DANG.
Evaluation on the performance of gene chip and linear probe technique in detecting MTB drug resistance in sputum samples from smear-positive pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(7): 738-742.
|
[8] |
Ming-wu LI,Ming-hong LAI,Meng MA,Rong WAN,Yuan XU,Chao-mei DU.
Analysis on the monitoring results of plasma-drug concentration of rifampicin in different dosage forms
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 645-649.
|
[9] |
Dong-xin LIU,Hui-wen ZHENG,Wen-cong HE,Yi-meng SONG,Ping HE,Bing ZHAO,Xi-chao OU,Chun-fa LIU,Yan-Lin ZHAO.
Analysis of strains identification and drug susceptibility characteristics of non-tuberculous mycobacterium isolated in Guangzhou
[J]. Chinese Journal of Antituberculosis, 2019, 41(5): 534-540.
|
[10] |
Cheng-cheng KONG,Hong-bing JIA,Hui-juan DUAN,Qian LIANG,Yi-feng MA,Yuan-yuan SHANG,Zhao-gang SUN.
Effect of pretreatment solution sediment of different characters on the pullution rate of MGIT 960 liquid culture
[J]. Chinese Journal of Antituberculosis, 2019, 41(4): 434-439.
|
[11] |
Xue-juan BAI,Yin-ping LIU,Jun-xian ZHANG,Jie WANG,Xue-qiong WU.
Direct detection of rifampicin and isoniazid resistance-associated genes in clinical specimens from the patients with tuberculosis using gene chip
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 138-144.
|
[12] |
Jing LI,Ya-ping LIANG,Zhuo WANG,Ji-ping CHEN,Zhi-cun WANG,Qian-hong WU.
The value of MicroDST and GeneXpert MTB/RIF test in detecting Mycobacterium tuberculosis resistance to rifampicin
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 162-168.
|
[13] |
JIANG Li-na,MU Cheng,SUN Rui,WANG Zhi-rui,DAI Wen-xi,WANG Chun-hua.
Detection value of the second-generation linear probe technique for drug resistance in Mycobacterium tuberculosis culture-positive isolates
[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1184-1190.
|
[14] |
YANG Tian-chi,CHEN Qin,CHEN Tong,YU Mei,LIN Xiang.
Analysis of catastrophic health expenditure and its influencing factors in patients with rifampicin-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1191-1196.
|
[15] |
Hui-na WU,Fu-sheng SUN,Qing-wen LIU,Zhong-lu RONG,Ji-dong ZHANG,Yang GAO,Yong-fu LI,Fei CHANG.
The value of fluorescent PCR probe melting curve analysis in detection of Mycobacterium tuberculosis complex for rifa-mpicin and isoniazid resistance
[J]. Chinese Journal of Antituberculosis, 2019, 41(1): 74-79.
|